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ABSTRAK
Tujuan: untuk mendeteksi kadar circulating endhotelial cells (CEC) dan ekspresi NFkB pada 3 kelompok 
subjek dengan kondisi tertentu. Metode: penelitian ini merupakan penelitian eksploratif menggunakan sampel 
darah perifer manusia. Subyek penelitian terdiri 3 kelompok yaitu kelompok orang sehat sebanyak 23 orang, 
kelompok yang memiliki satu atau lebih faktor risiko penyakit vaskular sebanyak 35 orang dan kelompok 
penderita penyakit vaskular (penyakit jantung koroner, diabetes melitus, strok) sebanyak 15 orang. CEC 
diisolasi dari peripheral blood mononuclear cell (PBMC). Kadar CEC diidentifikasi melalui pengukuran CD45 
dan CD146 dengan metode flowcytometry. Ekspresi NFkB diketahui dengan metoda ELISA (imgenex, USA). 
Hasil: nilai rerata tertinggi kadar CEC ditemukan pada kelompok sakit (28,6%). Nilai rerata tertinggi ekspresi 
NFκB (924,9495 pg/ml) ditemukan pada kelompok dengan faktor risiko. Adapun rerata terendah ekspresi NFκB 
dan CEC ditemukan pada kelompok sehat. Analisis ANOVA pada rentang kepercayaan 95% menunjukan bahwa 
terdapat perbedaan yang signifikan (p=0,00) kadar CEC dan ekspresi NFkB kelompok sehat dengan kelompok 
risiko dan kelompok sakit. Sedangkan ekspresi NFkB dan kadar CEC pada kelompok risiko tidak berbeda 
signifikan (p>0,05) dengan kelompok sakit. Kesimpulan: peningkatan kadar CEC dan ekspresi NFκB memiliki 
hubungan yang kuat dengan penyakit vaskular dan faktor risikonya.
Kata kunci: circulating endothelial cells (CEC), nuclear factor kappa beta (NFκB), peripheral blood 
mononuclear cell (PBMC), penyakit vaskular.
ABSTRACT
Aim: to detect the levels of CEC and expression of NFκB in the three groups of subjects with certain 
conditions. Methods: this study is an exploratory study using human peripheral blood samples. The study subjects 
comprised three groups, the group of 23 healthy people, a group of 35 people that has one or more risk factors 
for vascular disease and a group of 15 vascular disease patients (coronary heart disease, diabetes mellitus, 
stroke). CEC were isolated from peripheral blood mononuclear cells (PBMC). CEC level is identified through the 
measurement of CD45 and CD146 by flowcytometry method. NFκB expression is recognized by ELISA method 
(imgenex, USA). Results: the highest average levels of CEC were found in the sick group (28.6%). The highest 
average expression of NFκB (924.9495) is found in the group with risk factors. The lowest average expression 
of NFκB and CEC is found in the healthy group. Statistical analysis of ANOVA at the interval confidence of 95% 
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shows a significant difference (p=0.00) levels of CEC and NFκB expression between the healthy group with the 
group with the risk of cardiovascular disease (CVD) and patients with known CVD. Conclusion: increase of 
level CEC and NFκB expression has a strong relationship with vascular disease and its risk factors.
Key words: circulating endothelial cells (CEC), nuclear factor kappa beta (NFκB), peripheral blood 
mononuclear cell (PBMC), vascular disease.
INTRODUCTION
Atherosclerosis is a disorder in the blood 
vessel wall which is characterized by blockage 
(atheroma), so that blood flow becomes impaired.1 
The causes of atherosclerosis include dyslipidemia, 
free radicals, inflammation, and endothelial 
dysfunction.2 Endothelial dysfunction plays an 
important role in the pathogenesis, progression, 
and prognosis of the vascular disease. Another 
form of vascular disease is diabetes mellitus 
(DM). Hyperglycemic environment occurred 
in DM increases ROS production which leads 
to the oxidative state.3 ROS is a destructive 
substance against vascular and cause endothelial 
dysfunction afterward. According to Landim 
(2009) and Verma (2003), endothelial dysfunction 
initiates atherosclerosis.4 One of the markers of 
endothelial dysfunction is the increased number 
of circulating endothelial cells (CECs).
CEC identified as a marker of vascular 
damage in some diseases. Increasing number 
of CEC is correlated with disease activity.5 
CEC is found in the bloodstream due to various 
factors such as mechanical injury, subendothelial 
adhesion molecule, matrix protein binding 
defect and risk factors for atherosclerosis.6 In 
this case the risk factor mentioned is the impact 
of ROS that causes hyperglicaemia and also 
hyperlipidemia especially LDL. Oxidized LDL 
is also cytotoxic and served as a chemotactic 
factor for monocyte resulting in accumulation 
of inflammatory cells. Inflammation happens 
because ROS activates the transcription factor, 
Nuclear Factor Kappa Beta (NFκB). NFκB is 
a transcription factor which is susceptible to 
oxidation reaction.7
NFκB plays  an  impor tant  ro le  in 
chronic inflammatory process that occurs in 
atherosclerosis. Inflammation happens because 
NFκB is unintentionally activated.8,9 NFκB 
activation is caused by variety of stimuli such 
as local factors, namely vascular injury10, 
modification of LDL11, metabolic factors12,13, 
product and microbial agents14,15, cytokines16 
and T lymphocytes.9 Product activation of NFκB 
initiates the process of atherosclerosis with 
endothelial dysfunction, occurrence of platelet 
adhesion, migration and proliferation of smooth 
muscle cells.14 Increased levels of various 
inflammatory mediators were clearly seen in 
populations that were at risk of cardiovascular 
disease.17 
This study aimed to detect and compare the 
level of CEC and NFκB in humans among the 
healthy group, the group with CVD risk factors 
and those who suffer from CVD.
METHODS
This study is an exploratory study using 
human peripheral blood samples. The subject 
of the study as a whole amounted to 73 people 
divided into three groups. Group I, is a group of 
23 healthy people, drawn from the population of 
students at Brawijaya University with the criteria 
of 25-35 years of age, not smoking, normal 
weight (BMI/normal body mass index), normal 
lipid profile, normal blood pressure and not 
diabetic, not having hypertension and infection. 
Group II is a group that has one or more risk 
factors for vascular disease. Risk factors 
mentioned in this study were age over 50 years 
of age, smokers, obese; suffer from hypertension 
or diabetes, and lipid profile test results showed 
hyperlipidemia (total cholesterol, LDL and 
triglycerides and high density lipoprotein (HDL) 
below normal above normal). There are 35 
people included in this group II. They were taken 
from the employees at the Faculty who present 
at the medical examination at the main building. 
Group III is a group of 15 patients with vascular 
disease, who were already in the stage of stroke 
rehabilitation. Blood sampling is performed as 
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many as 7 cc for lipid profile examination, CEC 
and NFκB. CEC were isolated from peripheral 
blood mononuclear cells (PBMC). CEC levels 
identified through the measurement of CD45 and 
CD146 by flowcytometry method. Expression of 
NFκB (imgenex, USA) is identified by ELISA.
Isolation and Identification of Circulating 
Endothelial Cell (CEC)
CEC refers to the isolation in Blann et al 
(2005).18 Peripheral blood samples were taken 
using syringes. Peripheral blood mononuclear 
(PBMN) cell is separated from the blood using 
Histopaque 1077. PBMN cells amounted to 
100 μL were then incubated with 10 μL normal 
mouse serum (Sigma, USA) for five minutes 
and then re-suspended with 50 μL of anti 
human CD146-PE (SantaCruz, USA) and 50 
μL CD45-PE (SantaCruz, USA) by comparison 
1:100. Cells were incubated with antibodies for 
20 minutes at room temperature. Samples were 
diluted up to 1 μL and read with flowcytometry 
(FACS Callibur, BD).
Translocation Measurement of NFkB with 
ELISA Method
Total amount of PBMC were 106 cells per 
ml, diluted with PBS containing MgCl, and 
resuspended 4 xvol with lyses buffer (10 mM 
KCl, 10 mM Tris Cl, pH 7.9 containing 1 mM 
PMSF DDT and 60 um) in 4oC. Afterwards, 
it is incubated on ice for 20 minutes, and then 
homogenized with homogenizer. Centrifugation 
at 3000xg lasts for five minutes. Then, discard 
the supernatant. The pellet is washed two times 
with lysis buffer, 2 x vol. Resuspension  of pellets 
uses extraction buffer 4 x vol, (50 mM Tris Cl pH 
7.9, 0.42 M KCl, 5 mm MgCl, 0.1 mM EDTA, 
20% glycerol, 10% sucrose, 2 mm DDT, 60 um 
PMSF) which is stirred for 30 minutes and then 
centrifuged at 17,000 x g. Add (NH2)2SO4 in the 
supernatant (0.33 g/mL), stir for 30 minutes and 
centrifuge for 10 min at 15,000 x g. Then, pellet 
is resuspended with TM 1M, 0.5 x vol, (50 mM 
Tris Cl pH 7.9, 0.1 M KCl, 12.5 mM MgCl, 0.1 
mM EDTA, 20% glycerol, 1 mM DDT, 60um 
PMSF). Two times dialysis on the 1M TM buffer 
and centrifugation at 15 x g last for 10 minutes. 
Take the supernatant containing the cell nucleus 
protein extracts.
In p50/p65 of NFkB translocation test, the 
first step is to determine the amount used in the 
micro titer well. To manufacture the standard 
curve, 100 μL assay buffer is pipetted into the 
wells (as well blank), 100 μL is pipetted of p50/
p65 NFκB standards 1-7 into the mentioned well. 
For sample treatment, the thing to do is to pipette 
100 μL of each sample treatment and collect it 
into the well. Micro titer is incubated at 37°C for 
two hours. Each well is washed with wash buffer 
3x400 μL respectively for five minutes. Each 
well is filled with 100 μL of antibody, except 
the blank. Micro titer is incubated at 37°C for 1 
hour. Each well was washed with wash buffer 3x 
400 μL. Each well is filled 100 μL of conjugate, 
except in blank. Micro titer is incubated at 37°C 
for 30 minutes. Each well was washed with 
wash buffer 3x400 μL. TMB substrate as much 
as 100 μL is pipetted and added to each well, 
then incubated for 30 minutes at temperature 
room. Stop solution (HCl) as much as 100 μL is 
pipetted and added to each well for five minutes. 
Reading assessment of absorbency is done on 
the OD 492 nm.
The study was conducted after reviewed 
and approved by the research ethics committee 
of health, Faculty of Medicine of Brawijaya 
University number 069/EC/KEPK-JK/03/2011. 
All the study subjects were given information 
regarding the research which will be conducted 
(information sheet attached). After understanding 
the purpose of this study, the subjects were 
offered for willingness to follow, if they were 
willing then a consent form (informed consent 
attached) is given for signature. All recipients 
who were willing to follow the research were 
given the sheet to be filled based on interviews 
and direct measurement by the researchers, 
which include initials, age, gender, weight, 
height, blood pressure, history of disease 
(diabetes mellitus, hypertension, infection/TB, 
CVA ) and lifestyle (smoking, diet, exercise 
patterns).
The result of measurement of CEC and 
NFκB in each group differences were analyzed 
using ANOVA statistical test.
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RESULTS
The highest average levels of CEC were 
seen in the sick group (28.6%) (Table 1), 
while the highest average of NFκB expression 
(644.80 pg/ml) was found in the group with 
risk factor (Table 1). The lowest average level 
of CEC and expression of NFκB was found in 
the healthy group. Statistical analysis ANOVA 
at the confidence interval 95% indicates that 
there is a significant difference (p=0.00) CEC 
levels and expression of NFκB of the healthy 
group and the group with the risk group. While 
the CEC levels and  expression of NFκB of the 
group with risk did not different significantly 
(p>0.05) with the sick group.
DISCUSSION
CEC is a circulating endothelial cells 
participating along with blood flow or often 
defined as the expression of the membrane 
glycoprotein CD 146 and are rarely found in 
the blood of healthy individuals, but increased 
in patients with various conditions, such as 
inflammatory diseases, infections, metabolic 
disease and cardiovascular disease. The number 
of CEC was calculated by the method of flow 
cytometry (Figure 1-3). CEC Isolation refers 
to Blann et al (2005).18 CEC are rarely or its 
number is very few in healthy people so that 
flow cytometry was chosen because of its high 
levels of sensitivity. To identify the CEC, another 
Table 1. The comparison of circulating endhothelial cells (%) level and nuclear factor Kappa beta expression (pg/mL) 
among population groups
Population group
CEC (%) NFKB (pg/ml)
Mean ± SD 95% CI for Mean Mean ± SD 95% CI for mean
Healthy Group 5.65 ± 3.95a 3.94 - 7.35 166.64 ± 5.18a 144.22 - 189.06
Risk Group 23.27 ± 9.42bc 20.26 - 26.29 644.80 ± 2.53bc 504.51 - 785.20
Sick Group 28.60 ± 6.60cb 24.95 - 32.25 524.44 ± 3.52cb 411.93 - 636.95
Figure 1. Flowcytometry of CEC using CD45-FITC marker and CD146-PE on a sample from healthy group
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Figure 2. Flowcytometry of CEC using CD45-FITC marker and CD146-PE on a sample from  risk factor group
Figure 3. Flowcytometry of CEC using CD45-FITC marker and CD146-PE on a sample from sick group
marker is added to be more specific, namely the 
CD 45. CD 45 is a marker that exists in all white 
blood cells with varied intensity but not found in 
red blood cells. In relative relation, lymphocytes 
have a low SSC and high number of CD 45, 
granulocytes have the high number of SSC and 
low CD 45 number, while monocytes’ are among 
the granulocytes and lymphocytes. Based on the 
theory above, the part viewed from the results 
of flow cytometry is in the upper right or on the 
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lymphocyte area. This area is commonly called 
double positive because it shows both marker 
that are the number of CD 45 and CD 146 so 
that it is more representative of the number of 
CEC in the blood.19
Layer of endothelial cells constitute the 
vascular structure construction attached to 
the basal membrane (basement membrane). 
Endothelial cells overlay the inner part of 
the lumen from all blood vessels and acts as 
a connector between blood circulation and 
plain muscle cells of blood vessels. Cell of 
endothelium plays an important role in the 
vascular system because it facilitates a variety of 
complex functions of plain muscle cell of blood 
vessels and cells in the blood compartment. 
Various studies have shown that endothelial 
cells play an important role in the process of 
homeostasis that occurs through the integration 
of various chemical mediators. This system 
has a good effect on the plain muscle cells of 
blood vessels and blood cells that can cause 
a variety of changes such as vasodilatation or 
vasoconstriction that can regulate the blood 
supply needs of all human organs, growth and or 
changes in panoptic characteristics of the plain 
muscle cells of blood vessels, changes in pro-
inflammation or anti-inflammation, maintaining 
blood viscosity and prevent bleeding.20 Recent 
studies identify the dysfunction of Endothelia by 
measuring circulating endothelial cells (CEC).6 
In healthy condition, endothelial cells will 
remain in the basal membrane and less likely to 
experience detachment in the bloodstream in the 
form of circulating endothelial cells (CEC). Like 
the case in this study, the average of the lowest 
level of CEC (5.65%) and the average of the 
lowest level of NFκB expression (166.64) was 
found in the healthy group. The healthy group 
in this study is represented by a population of 
Brawijaya University students with criteria of 
25-35 years of age, not smoking, healthy weight 
(BMI/normal body mass index), normal lipid 
profile, normal blood pressure and not diabetic, 
not having hypertension and infection. The result 
of the analysis by using one way of ANOVA 
notes significant differences of both CEC and the 
expression levels of NFκB between the healthy 
group and the other groups (the group with risk 
and the sick group). The lowness of CEC level 
and expression of NFκB in the healthy group 
population showed that a small possibility of the 
occurrence of a vascular inflammatory processes 
that trigger endothelial dysfunction.
CEC was found in the bloodstream 
due to various factors such as mechanical 
injury, adhesion molecule of subendothelium, 
defect matrix protein binding and risk factors 
for atherosclerosis.6 One of risk factors of 
atherosclerosis is DM because oxidative stress 
occurred within leads to vascular.21 Mechanism of 
endothelial cell release is complex and influenced 
by many factors, including the mechanisms of 
endothelial injury, atherosclerosis risk factors 
and endothelial adhesion damage and apoptotic 
cell with decreased function of the cytoskeleton. 
The highest average level of CEC in this study 
was found in the sick group with CVD (28.6%). 
Pathological conditions such as dyslipidemia, 
ischemic heart disease, coronary angioplasty, 
and heart disease and lung cancer, such as acute 
myocardial infarction, stroke and hypertension 
increase the number of CEC.5 In addition, other 
factors that cause the release of endothelial cells 
is the presence of interference with attachment 
factors endothelial cells, proteases or cytokines 
that mediate the release of endothelial, or due 
to apoptosis.
The highest average expression of NFκB 
(644.80 pg/ml) was found in the risk group. 
NFκB activation is induced by ROS (reactive 
oxygen species) of a product, one of which is 
generated due to dyslipidemia, hiperglyemia 
and other risk factors for atherosclerosis. Data 
of the group with risk (524.44 pg/ml) in this 
group showed a tendency of atherosclerosis. 
Factor of age is more than 50 years of age, 
smokers, obese; suffer from hypertension or 
diabetes, and the test result of lipid profile 
showed hyperlipidemia (total cholesterol, LDL 
and triglycerides above normal and HDL below 
normal). These conditions will increase H2O2, 
which causes the increase of a phosphate cluster 
so that bond of NFκB-IKB gets loose. This 
causes NFκB to move into the nucleus of the 
cell automatically, because the P50 has a nuclear 
localization signal (NLS) is inhibited when 
bound to IKBNFKB function as a transcription 
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factor genes, especially genes involved in 
the immune response and Inflammation and 
apoptosis.22 Since the beginning NFκB is 
involved in the pathogenesis of atherosclerosis 
by stimulating inflammatory cells and molecules 
that facilitate adhesion and apoptosis which 
cause atherosclerotic plaque buried and also 
cause rupture of the plaque. The high level of 
NFκB expression of the group with risk showed 
that the activation of NFκB precedes endothelial 
dysfunction so that CEC levels are still relatively 
low compared to the sick group. NFκB plays 
an important role in chronic inflammatory 
process that occurs in atherosclerosis.9 NFκB 
activation stimulates the expression of pro-
inflammatory genes that initiate the occurrence 
of endothelial dysfunction, the occurrence of 
platelet aggregation, migration and proliferation 
of smooth muscle cells.14 Increased levels of 
various inflammatory mediators is clearly seen 
in populations with risk factors of cardiovascular 
disease.17
CONCLUSION
CEC and NFκB were detected in human 
PBMC of all groups. There is a significant 
difference of CEC levels and expression of 
NFκB between the healthy group and the group 
with the risk of vascular diseases and group 
of patients with known CVD. While the CEC 
levels and expression of NFκB in the groups 
with risk did not different significantly with the 
sick group.
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